From: Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study
Year | Rate of prescribing per 1000 GMS population (95 % confidence interval) | Net ingredient cost in € (% of all prescriptions) | Total expenditure in € (% of all prescriptions) |
---|---|---|---|
2002 | 3.77 (3.53–4.01) | 68,945(0.70) | 89,254 (0.64) |
2003 | 4.91 (4.64–5.18) | 236,180 (2.07) | 268,810(1.67) |
2004 | 5.67 (5.37–5.97) | 351,204 (2.81) | 393,406 (2.28) |
2005 | 6.84 (6.51–7.17) | 464,287 (3.34) | 518,225 (2.75) |
2006 | 6.77 (6.46–7.08) | 529,926 (3.36) | 596,176 (2.76) |
2007 | 7.42 (7.10–7.74) | 783,868 (4.42) | 863,930 (3.59) |
2008 | 7.61 (7.30–7.92) | 940,133 (4.85) | 1,036,285 (3.89) |
2009 | 7.73 (7.43–8.03) | 1,100,869 (5.10) | 1,205,242 (4.00) |
2010 | 7.80 (7.52–8.08) | 1,279,381(5.33) | 1,387,443 (4.12) |
2011 | 8.63 (8.34–8.92) | 1,410,443 (5.22) | 1,532,016 (4.01) |